Amil Sinha
Papers
2
Total Citations
9
H-Index
2
About
Amil Sinha is a dedicated urological researcher whose work focuses on improving post-surgical quality of life for prostate cancer patients, with a particular emphasis on erectile function recovery and continence outcomes following robot-assisted radical prostatectomy (RARP). His major contributions center on the strategic use of phosphodiesterase-5 inhibitors (PDE5i) in the immediate postoperative period. Through prospective, single-surgeon data collection, Sinha has demonstrated that early initiation of PDE5i therapy can significantly enhance erectile function outcomes shortly after RARP, offering patients a faster return to sexual health. His 2021 paper on this topic, with 7 citations, and a preceding 2020 abstract, have helped shape clinical protocols around postoperative rehabilitation. By systematically evaluating the timing of intervention, Sinha’s work provides evidence-based guidance for urologists seeking to optimize recovery trajectories. His research not only addresses a critical aspect of patient well-being but also underscores the importance of early, targeted therapy in surgical oncology. For students and clinicians alike, Sinha’s findings offer a practical, patient-centered approach to mitigating the functional consequences of prostate cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1
- 2